Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

China flag China · Delayed Price · Currency is CNY
4.290
-0.050 (-1.15%)
Jul 21, 2026, 3:00 PM CST
Market Cap10.88B -5.6%
Revenue (ttm)6.69B +5.0%
Net Income483.42M -18.9%
EPS0.19 -16.1%
Shares Out 2.54B
PE Ratio22.20
Forward PEn/a
Dividend0.15 (3.46%)
Ex-Dividend DateJun 24, 2026
Volume68,714,360
Open4.330
Previous Close4.340
Day's Range4.270 - 4.390
52-Week Range3.770 - 5.170
Beta0.23
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHA:600572

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it off... [Read more]

Sector Healthcare
Founded 1969
Employees 7,826
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600572
Full Company Profile

Financial Performance

In 2025, SHA:600572's revenue was 6.47 billion, a decrease of -0.64% compared to the previous year's 6.52 billion. Earnings were 474.36 million, a decrease of -23.79%.

Financial Statements